[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:leiomyosarcoma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":151,"states":152},"Leiomyosarcoma",23,22,[8,16,23,30,36,42,48,54,61,67,73,79,85,91,96,102,107,113,119,125,131,137,144],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT04535271","Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Soft Tissue Sarcoma",[12],"Phase 2","RECRUITING","2026-08-26T02:17:27.435233Z","2026-05-05T02:43:29.479794Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT06308419","A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions",[20],"Phase 1","2026-08-26T02:19:22.562392Z","2026-05-05T02:43:29.070302Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":28,"content_modified":29},"NCT04031677","Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma",[27],"Phase 3","2026-08-26T02:17:02.694423Z","2026-05-05T02:43:28.835529Z",{"nct_id":31,"title":32,"phases":33,"status":13,"updated_at":34,"content_modified":35},"NCT06957431","Zanzalintinib Combined With Eribulin in Advanced Liposarcoma and Leiomyosarcoma",[20],"2026-08-26T02:19:08.084946Z","2026-05-05T02:43:28.742384Z",{"nct_id":37,"title":38,"phases":39,"status":13,"updated_at":40,"content_modified":41},"NCT07516925","A Study of Ivonescimab in People With Leiomyosarcoma",[12],"2026-08-26T02:16:57.705506Z","2026-05-05T02:43:28.501535Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT06528769","Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma",[12],"2026-08-26T02:17:19.710918Z","2026-05-05T02:43:27.966241Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT07125183","Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma",[12],"2026-08-26T02:16:00.194860Z","2026-05-05T02:43:27.283090Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":59,"content_modified":60},"NCT06975293","STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas",[58],"Phase 1\u002FPhase 2","2026-08-26T02:16:33.772093Z","2026-05-05T02:43:29.479024Z",{"nct_id":62,"title":63,"phases":64,"status":13,"updated_at":65,"content_modified":66},"NCT06498648","Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma",[58],"2026-08-26T02:17:04.346841Z","2026-05-05T02:43:28.316488Z",{"nct_id":68,"title":69,"phases":70,"status":13,"updated_at":71,"content_modified":72},"NCT03016819","Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)",[27],"2026-08-26T02:18:13.438956Z","2026-05-05T02:43:27.260312Z",{"nct_id":74,"title":75,"phases":76,"status":13,"updated_at":77,"content_modified":78},"NCT05711615","Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma",[20],"2026-08-26T02:19:30.857183Z","2026-07-05T05:32:16.811405Z",{"nct_id":80,"title":81,"phases":82,"status":13,"updated_at":83,"content_modified":84},"NCT06571734","XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma",[12],"2026-08-26T02:17:14.343713Z","2026-07-05T05:32:16.766529Z",{"nct_id":86,"title":87,"phases":88,"status":13,"updated_at":89,"content_modified":90},"NCT06789172","A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors",[20],"2026-08-26T02:16:18.872924Z","2026-07-05T05:32:16.698119Z",{"nct_id":92,"title":93,"phases":94,"status":13,"updated_at":14,"content_modified":95},"NCT04902443","Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV",[20],"2026-06-18T12:24:02.872345Z",{"nct_id":97,"title":98,"phases":99,"status":13,"updated_at":100,"content_modified":101},"NCT05227326","AOH1996 for the Treatment of Refractory Solid Tumors",[20],"2026-08-26T02:19:20.945539Z","2026-05-05T02:43:26.920202Z",{"nct_id":103,"title":104,"phases":105,"status":13,"updated_at":46,"content_modified":106},"NCT05653388","Metastatic Leiomyosarcoma Biomarker Protocol",[],"2026-07-05T05:32:16.806328Z",{"nct_id":108,"title":109,"phases":110,"status":13,"updated_at":111,"content_modified":112},"NCT07633756","A Phase 1b, Open-Label Study Of REC-617, A Selective CDK7 Inhibitor, In Patients With Metastatic Or Unresectable RB1-Negative Leiomyosarcoma After Prior Systemic Therapy",[20],"2026-08-26T02:19:15.498463Z","2026-06-14T18:39:22.252532Z",{"nct_id":114,"title":115,"phases":116,"status":13,"updated_at":117,"content_modified":118},"NCT06875700","Beliefs, Attitudes, and Response to Genetic Testing in SarcomaPatients",[],"2026-08-26T02:17:39.048487Z","2026-05-13T02:55:06.588152Z",{"nct_id":120,"title":121,"phases":122,"status":13,"updated_at":123,"content_modified":124},"NCT04925089","Localized Leiomyosarcoma Biomarker Protocol",[],"2026-08-26T02:18:46.137046Z","2026-05-13T02:55:06.274833Z",{"nct_id":126,"title":127,"phases":128,"status":13,"updated_at":129,"content_modified":130},"NCT00001238","Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders",[],"2026-08-26T02:16:34.792807Z","2026-07-05T18:42:10.720145Z",{"nct_id":132,"title":133,"phases":134,"status":13,"updated_at":135,"content_modified":136},"NCT01793168","Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford",[],"2026-08-26T02:17:29.353236Z","2026-05-13T02:55:06.077983Z",{"nct_id":138,"title":139,"phases":140,"status":13,"updated_at":142,"content_modified":143},"NCT07628634","Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w\u002F Solid Tumors",[141],"Early Phase 1","2026-08-26T02:18:00.873391Z","2026-06-06T00:48:49.527814Z",{"nct_id":145,"title":146,"phases":147,"status":148,"updated_at":149,"content_modified":150},"NCT06088290","Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo)",[27],"ACTIVE_NOT_RECRUITING","2026-08-03T03:02:32.170340Z","2026-05-05T02:43:29.677653Z",[],[153,157,160,164,168,172,175,178,181,184,187,191,194,197,200,203,207],{"state":154,"count":155,"slug":156},"California",10,"california",{"state":158,"count":155,"slug":159},"Texas","texas",{"state":161,"count":162,"slug":163},"Michigan",7,"michigan",{"state":165,"count":166,"slug":167},"New York",6,"new-york",{"state":169,"count":170,"slug":171},"Colorado",5,"colorado",{"state":173,"count":170,"slug":174},"Florida","florida",{"state":176,"count":170,"slug":177},"Massachusetts","massachusetts",{"state":179,"count":170,"slug":180},"Minnesota","minnesota",{"state":182,"count":170,"slug":183},"Missouri","missouri",{"state":185,"count":170,"slug":186},"Tennessee","tennessee",{"state":188,"count":189,"slug":190},"Arizona",4,"arizona",{"state":192,"count":189,"slug":193},"Illinois","illinois",{"state":195,"count":189,"slug":196},"Maryland","maryland",{"state":198,"count":189,"slug":199},"Ohio","ohio",{"state":201,"count":189,"slug":202},"Pennsylvania","pennsylvania",{"state":204,"count":205,"slug":206},"Virginia",3,"virginia",{"state":208,"count":205,"slug":209},"Washington","washington"]